Catalase alleviates cardiomyocyte dysfunction in diabetes: role of Akt, Forkhead transcriptional factor and silent information regulator 2

Life Sciences

Volumn 81, Issue 11, 2007, Pages 895-905

  Turdi, Subat ^a   Li, Qun ^a   Lopez, Faye L ^a   Ren, Jun ^a  

^a UNIVERSITY OF WYOMING   (United States)

Author keywords

Antioxidant; Diabetes; Intracellular Ca2+ transients; Myocyte; Shortening

Indexed keywords

CALCIUM; CATALASE; FORKHEAD TRANSCRIPTION FACTOR; GLYCOGEN SYNTHASE KINASE 3BETA; PROTEIN KINASE B BETA; REACTIVE OXYGEN METABOLITE; SILENT INFORMATION REGULATOR PROTEIN 2; STREPTOZOCIN; TRANSCRIPTION FACTOR FKHRL1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC CARDIOMYOPATHY; GENE OVEREXPRESSION; HEART ATRIUM FUNCTION; HEART LEFT VENTRICLE DP-DT; HEART MUSCLE CONTRACTILE FORCE; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE FUNCTION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN PHOSPHORYLATION; STREPTOZOCIN DIABETES; TRANSGENIC MOUSE; TREATMENT RESPONSE; UPREGULATION; WESTERN BLOTTING;

ANIMALS; CARDIOMYOPATHIES; CASPASE 3; CATALASE; DIABETES COMPLICATIONS; DIABETES MELLITUS, EXPERIMENTAL; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; GLYCOGEN SYNTHASE KINASE 3; MICE; MYOCYTES, CARDIAC; NAPHTHALENES; PROTO-ONCOGENE PROTEINS C-AKT; PYRONES; REACTIVE OXYGEN SPECIES; SIRTUINS;

MUS MUSCULUS;

EID: 34548486662     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.07.029     Document Type: Article

References (37)

1. Alcendor R.R., Kirshenbaum L.A., Imai S., Vatner S.F., and Sadoshima J. Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes. Circulation Research 95 (2004) 971-980
2. Bouchard C., Marquardt J., Bras A., Medema R.H., and Eilers M. Myc-induced proliferation and transformation require Akt-mediated phosphorylation of FoxO proteins. EMBO Journal 23 (2004) 2830-2840
3. Cai L., and Kang Y.J. Oxidative stress and diabetic cardiomyopathy: a brief review. Cardiovascular Toxicology 1 (2001) 181-193
4. Ceylan-Isik A.F., LaCour K.H., and Ren J. Gender disparity of streptozotocin-induced intrinsic contractile dysfunction in murine ventricular myocytes: role of chronic activation of Akt. Clinical and Experimental Pharmacology and Physiology 33 (2006) 102-108
5. Ceylan-Isik A.F., LaCour K.H., and Ren J. Sex difference in cardiomyocyte function in normal and metallothionein transgenic mice: the effect of diabetes mellitus. Journal of Applied Physiology 100 (2006) 1638-1646
6. Dong F., Fang C.X., Yang X., Zhang X., Lopez F.L., and Ren J. Cardiac overexpression of catalase rescues cardiac contractile dysfunction induced by insulin resistance: role of oxidative stress, protein carbonyl formation and insulin sensitivity. Diabetologia 49 (2006) 1421-1433
7. Duan J., McFadden G.E., Borgerding A.J., Norby F.L., Ren B.H., Ye G., Epstein P.N., and Ren J. Overexpression of alcohol dehydrogenase exacerbates ethanol-induced contractile defect in cardiac myocytes. American Journal of Physiology. Heart and Circulatory Physiology 282 (2002) H1216-H1222
8. Duan J., Zhang H.Y., Adkins S.D., Ren B.H., Norby F.L., Zhang X., Benoit J.N., Epstein P.N., and Ren J. Impaired cardiac function and IGF-I response in myocytes from calmodulin-diabetic mice: role of Akt and RhoA. American Journal of Physiology. Endocrinology, Metabolism and Gastrointestinal Physiology 284 (2003) E366-E376
9. Essers M.A., Weijzen S., Vries-Smits A.M., Saarloos I., de Ruiter N.D., Bos J.L., and Burgering B.M. FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. EMBO Journal 23 (2004) 4802-4812
10. Fang C.X., Dong F., Ren B.H., Epstein P.N., and Ren J. Metallothionein alleviates cardiac contractile dysfunction induced by insulin resistance: role of Akt phosphorylation, PTB1B, PPARgamma and c-Jun. Diabetologia 48 (2005) 2412-2421
11. Fein F.S., and Sonnenblick E.H. Diabetic cardiomyopathy. Cardiovascular Drugs and Therapy 8 (1994) 65-73
12. Furukawa-Hibi Y., Kobayashi Y., Chen C., and Motoyama N. FOXO transcription factors in cell-cycle regulation and the response to oxidative stress. Antioxidants and Redox Signalling 7 (2005) 752-760
13. Grubisha O., Smith B.C., and Denu J.M. Small molecule regulation of Sir2 protein deacetylases. FEBS Journal 272 (2005) 4607-4616
14. Haider N., Narula N., and Narula J. Apoptosis in heart failure represents programmed cell survival, not death, of cardiomyocytes and likelihood of reverse remodeling. Journal of Cardiac Failure 8 (2002) S512-S517
15. Hardt S.E., and Sadoshima J. Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development. Circulation Research 90 (2002) 1055-1063
16. Hu M.C., Lee D.F., Xia W., Golfman L.S., Ou-Yang F., Yang J.Y., Zou Y., Bao S., Hanada N., Saso H., Kobayashi R., and Hung M.C. IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 117 (2004) 225-237
17. Huisamen B. Protein kinase B in the diabetic heart. Molecular and Cellular Biochemistry 249 (2003) 31-38
18. Laviola L., Belsanti G., Davalli A.M., Napoli R., Perrini S., Weir G.C., Giorgino R., and Giorgino F. Effects of streptozocin diabetes and diabetes treatment by islet transplantation on in vivo insulin signaling in rat heart. Diabetes 50 (2001) 2709-2720
19. Li S.Y., Gomelsky M., Duan J., Zhang Z., Gomelsky L., Zhang X., Epstein P.N., and Ren J. Overexpression of aldehyde dehydrogenase-2 (ALDH2) transgene prevents acetaldehyde-induced cell injury in human umbilical vein endothelial cells: role of ERK and p38 mitogen-activated protein kinase. Journal of Biological Chemistry 279 (2004) 11244-11252
20. Matsui T., Tao J., del Monte F., Lee K.H., Li L., Picard M., Force T.L., Franke T.F., Hajjar R.J., and Rosenzweig A. Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation 104 (2001) 330-335
21. Michael A., Haq S., Chen X., Hsich E., Cui L., Walters B., Shao Z., Bhattacharya K., Kilter H., Huggins G., Andreucci M., Periasamy M., Solomon R.N., Liao R., Patten R., Molkentin J.D., and Force T. Glycogen synthase kinase-3beta regulates growth, calcium homeostasis, and diastolic function in the heart. Journal of Biological Chemistry 279 (2004) 21383-21393
22. Norby F.L., Wold L.E., Duan J., Hintz K.K., and Ren J. IGF-I attenuates diabetes-induced cardiac contractile dysfunction in ventricular myocytes. American Journal of Physiology. Endocrinology, Metabolism and Gastrointestinal Physiology 283 (2002) E658-E666
23. Norby F.L., Aberle N.S., Kajstura J., Anversa P., and Ren J. Transgenic overexpression of insulin-like growth factor I prevents streptozotocin-induced cardiac contractile dysfunction and beta-adrenergic response in ventricular myocytes. Journal of Endocrinology 180 (2004) 175-182
24. O'Neill B.T., and Abel E.D. Akt1 in the cardiovascular system: friend or foe?. Journal of Clinical Investigation 115 (2005) 2059-2064
25. Penckofer S., Schwertz D., and Florczak K. Oxidative stress and cardiovascular disease in type 2 diabetes: the role of antioxidants and pro-oxidants. Journal of Cardiovascular Nursing 16 (2002) 68-85
26. Privratsky J.R., Wold L.E., Sowers J.R., Quinn M.T., and Ren J. AT1 blockade prevents glucose-induced cardiac dysfunction in ventricular myocytes: role of the AT1 receptor and NADPH oxidase. Hypertension 42 (2003) 206-212
27. Ren J., and Davidoff A.J. Diabetes rapidly induces contractile dysfunctions in isolated ventricular myocytes. American Journal of Physiology 272 (1997) H148-H158
28. Ren J., and Bode A.M. Altered cardiac excitation-contraction coupling in ventricular myocytes from spontaneously diabetic BB rats. American Journal of Physiology. Heart and Circulatory Physiology 279 (2000) H238-H244
29. Ren J., and Ceylan-Isik A.F. Diabetic cardiomyopathy: do women differ from men?. Endocrine 25 (2004) 73-83
30. Ren J., Sowers J.R., Walsh M.F., and Brown R.A. Reduced contractile response to insulin and IGF-I in ventricular myocytes from genetically obese Zucker rats. American Journal of Physiology. Heart and Circulatory Physiology 279 (2000) H1708-H1714
31. Shen X., Ye G., Metreveli N.S., and Epstein P.N. Cardiomyocyte defects in diabetic models and protection with cardiac-targeted transgenes. Methods in Molecular Medicine 112 (2005) 379-388
32. Skurk C., Izumiya Y., Maatz H., Razeghi P., Shiojima I., Sandri M., Sato K., Zeng L., Schiekofer S., Pimentel D., Lecker S., Taegtmeyer H., Goldberg A.L., and Walsh K. The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling. Journal of Biological Chemistry 280 (2005) 20814-20823
33. Tirosh A., Rudich A., Potashnik R., and Bashan N. Oxidative stress impairs insulin but not platelet-derived growth factor signalling in 3T3-L1 adipocytes. Biochemical Journal 355 (2001) 757-763
34. Wold L.E., Ceylan-Isik A.F., and Ren J. Oxidative stress and stress signaling: menace of diabetic cardiomyopathy. Acta Pharmaceutica Sinica 26 (2005) 908-917
35. Ye G., Metreveli N.S., Ren J., and Epstein P.N. Metallothionein prevents diabetes-induced deficits in cardiomyocytes by inhibiting reactive oxygen species production. Diabetes 52 (2003) 777-783
36. Zhang X., Dong F., Li Q., Borgerding A.J., Klein A.L., and Ren J. Cardiac overexpression of catalase antagonizes ADH-associated exacerbation of contractile depression and stress signaling following acute ethanol exposure in murine myocytes. Journal of Applied Physiology 99 (2005) 2246-2254
37. Zhang X., Klein A.L., Alberle N.S., Norby F.L., Ren B.H., Duan J., and Ren J. Cardiac-specific overexpression of catalase rescues ventricular myocytes from ethanol-induced cardiac contractile defect. Journal of Molecular and Cellular Cardiology 35 (2003) 645-652